Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes

被引:33
作者
Chang, SC [1 ]
MacRobert, AJ [1 ]
Bown, SG [1 ]
机构
[1] TZU CHI GEN HOSP,HUALIEN,TAIWAN
关键词
photosensitizing agents; phototherapy; protoporphyrins; aminolevulinic acid;
D O I
10.1016/S0022-5347(01)66191-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Photodynamic therapy (PDT) has the potential to treat extensive premalignant lesions and microinvasive tumors in the bladder, but its use has been hampered by the risk of detrusor muscle damage and prolonged skin photosensitivity. We have shown that the rat urothelium can be sensitized by selectively using a 10% solution of 5-aminolevulinic acid (ALA) at pH 5.5 administered intravesically. This paper evaluates the photodynamic effects on sensitized bladders. Materials and Methods: The bladders of Wistar rats were instilled with ALA solutions of different concentrations at pH 5.5 and subsequently treated with laser light at 630 nm. Bladders were harvested 1 to 7 days after PDT for histological assessment. Results: Under optimum conditions (10% intralipid diffusion medium, light dose 50J) uniform urothelial necrosis was seen after 1 to 2 days; it healed in 7 days without damage to the underlying muscle layer although some increase in collagen was seen in the lamina propria. Overtreatment or poor light distribution resulted in muscle necrosis and scarring. Conclusions: Selective urothelial necrosis is possible with PDT using intravesical ALA. There is now sufficient data for pilot clinical trials to start photodynamic therapy for management of superficial bladder cancer or carcinoma in situ.
引用
收藏
页码:1749 / 1753
页数:5
相关论文
共 20 条
[1]  
BAGHDASSARIAN R, 1985, J UROLOGY, V136, P126
[2]   FLUORESCENCE DISTRIBUTION AND PHOTODYNAMIC EFFECT OF ALA-INDUCED PP-IX IN THE DMH RAT COLONIC TUMOR-MODEL [J].
BEDWELL, J ;
MACROBERT, AJ ;
PHILLIPS, D ;
BOWN, SG .
BRITISH JOURNAL OF CANCER, 1992, 65 (06) :818-824
[3]   TREATMENT OF TRANSITIONAL CELL-CARCINOMA OF THE BLADDER WITH HEMATOPORPHYRIN DERIVATIVE PHOTOTHERAPY [J].
BENSON, RC ;
KINSEY, JH ;
CORTESE, DA ;
FARROW, GM ;
UTZ, DC .
JOURNAL OF UROLOGY, 1983, 130 (06) :1090-1095
[4]  
CHANG SC, 1994, P SOC PHOTO-OPT INS, V2371, P289
[5]  
CORTI L, 1989, Lasers in Medical Science, V4, P155, DOI 10.1007/BF02032429
[6]   WHOLE BLADDER WALL PHOTODYNAMIC THERAPY WITH IN SITU LIGHT DOSIMETRY FOR CARCINOMA INSITU OF THE BLADDER [J].
DHALLEWIN, MA ;
BAERT, L ;
MARIJNISSEN, JPA ;
STAR, WM .
JOURNAL OF UROLOGY, 1992, 148 (04) :1152-1155
[7]  
Foote C.S., 1976, FREE RADICALS BIOL, V11, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X
[8]   COMPLICATIONS OF WHOLE BLADDER DIHEMATOPORPHYRIN ETHER PHOTODYNAMIC THERAPY [J].
HARTY, JI ;
AMIN, M ;
WIEMAN, TJ ;
TSENG, MT ;
ACKERMAN, D ;
BROGHAMER, W .
JOURNAL OF UROLOGY, 1989, 141 (06) :1341-1346
[9]   PHOTORADIATION THERAPY WITH HEMATOPORPHYRIN DERIVATIVE IN EARLY AND STAGE-1 LUNG-CANCER [J].
HAYATA, Y ;
KATO, H ;
KONAKA, C ;
AMEMIYA, R ;
ONO, J ;
OGAWA, I ;
KINOSHITA, K ;
SAKAI, H ;
TAKAHASHI, H .
CHEST, 1984, 86 (02) :169-177
[10]   HEMATOPORPHYRIN DERIVATIVE - POSSIBLE AID IN DIAGNOSIS AND THERAPY OF CARCINOMA OF BLADDER [J].
KELLY, JF ;
SNELL, ME .
JOURNAL OF UROLOGY, 1976, 115 (02) :150-151